Board of Directors

Samuel Broder is the former head of the National Cancer Institute (NCI), the largest and most important Agency for cancer research in the world. President Ronald Reagan appointed Dr. Broder to serve as Director of the NCI in 1989, and he held the position for six years.  While at the NCI, he also oversaw the … Read more

Casey Cunningham, MD is the Chief Scientific Officer of Santé Ventures. Dr. Cunningham received his fellowship training in oncology and hematology at the Harvard Medical School, where he subsequently served on the faculty for a number of years. In 1999, he became the Associate Director of the Mary Crowley Cancer Research Institute in Dallas, Tx. … Read more

Omar H. Khalil manages Santé’s Boston Office and concentrates on biotechnology, where he partners with scientific founders and entrepreneurs across multiple therapeutic areas and modalities. Omar joined Santé in 2007 and rejoined in 2020 after holding various transactional and operational leadership roles within the pharmaceutical and biotech industry. He held senior leadership roles with Baxter International, … Read more

Laurent Humeau is Chief Scientific Officer at Inovio. He works to ensure continuous and strategic growth of INOVIO’s pipeline by introducing a constant flow of innovative concepts and cycling them from early-stage discovery and development through clinical application and patient monitoring. He provides technical and strategic leadership across multiple teams that are essential to upstream … Read more

Mr. Lee is Head of Korea Investment Partners (KIP’s) US office based in Silicon Valley and actively explores cross-border investments to contribute to the global expansion of Korea Investment Partners.  He is currently managing over 12 companies in his investment portfolio and participates actively on more than 7  boards. Portfolio companies range from biotech/healthcare companies … Read more

José Ochoa is a Venture Partner at Flerie Invest, a European biotech and pharma investor managing a portfolio of more than 25 companies in the US, UK, Sweden and Israel.  With over 25 years of experience in the life sciences sector, José has successfully executed a variety of transactions, including mergers, acquisitions, joint ventures, and … Read more

Dr. Sardesai founded Geneos after building Inovio Pharmaceuticals into a Phase III cancer and infectious disease immunotherapy company serving as its Chief Operating Officer. He held positions of increasing responsibility after joining the company in 2006 where he helped formulate the company’s product development and growth strategies and reorganized the company into a DNA vaccine … Read more